Covered recipient · General Payments record
REBECCA K CUTCHIN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health
General Payments · PY2021–2024
$3,049.35
- Reported across 123 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,092.97 | 48 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $120.71 | 5 |
| Acerta Pharma LLC | $95.81 | 5 |
| EISAI INC. | $71.84 | 3 |
| Pharmacosmos Therapeutics Inc. | $69.44 | 3 |
| Janssen Biotech, Inc. | $68.39 | 2 |
| PFIZER INC. | $65.69 | 3 |
| Takeda Pharmaceuticals U.S.A., Inc. | $51.40 | 2 |
| E.R. Squibb & Sons, L.L.C. | $50.70 | 2 |
| PharmaEssentia USA Corporation | $43.88 | 2 |
| Ipsen Biopharmaceuticals, Inc | $42.78 | 2 |
| Incyte Corporation | $36.59 | 2 |
| Alexion Pharmaceuticals, Inc. | $29.89 | 1 |
| Adaptive Biotechnologies Corporation | $29.08 | 1 |
| Gilead Sciences, Inc. | $28.02 | 1 |
| Daiichi Sankyo Inc. | $27.76 | 1 |
| Lilly USA, LLC | $24.96 | 1 |
| ADC Therapeutics America, Inc. | $23.70 | 1 |
| Octapharma USA, Inc. | $22.51 | 1 |
| Karyopharm Therapeutics Inc. | $22.24 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $21.27 | 1 |
| Agios Pharmaceuticals, Inc. | $21.09 | 1 |
| Merck Sharp & Dohme Corporation | $21.05 | 1 |
| SECURA BIO, INC. | $19.26 | 1 |
| ABBVIE INC. | $18.47 | 1 |
| Astellas Pharma US Inc | $17.91 | 1 |
| Celgene Corporation | $17.87 | 1 |
| Regeneron Healthcare Solutions, Inc. | $15.38 | 1 |
| GlaxoSmithKline, LLC. | $15.28 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (48)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.